Pmh4 - Pharmacoeconomics of Atypical Antipsychotics Induced Metabolic Syndrome: A Critical Evaluation of Cost Implications and Health Outcomes

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1641
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Metabolic Effect of Atypical Antipsychotics

Kansas Journal of Medicine
2010English

Understanding Health Outcomes and Pharmacoeconomics

2017English

Metabolic Effects of Treatment With Atypical Antipsychotics

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2004English

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Atypical Antipsychotics

PharmacoEconomics & Outcomes News
1999English

Atypical Antipsychotics

2004English

Atypical Antipsychotics

2004English

Atypical Neuroleptic Malignant Syndrome or Serotonin Toxicity Associated With Atypical Antipsychotics?

Current Drug Safety
ToxicologyPharmacology
2009English

Pmh24 - Cost Implications of Antipsychotics Drugs: A Hospital Budget Impact Model

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy